Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

RSRF-Funded Research Yields Novel Function for Rett Syndrome Gene

19.10.2005


Huda Zoghbi, of Baylor College of Medicine and the Howard Hughes Medical Institute and Juan Young, also of Baylor and colleagues report in the online Early Edition of the Proceedings of the National Academy of Science, posted the week of October 17, 2005, that the Rett Syndrome gene, MECP2, regulates RNA splicing. This work was funded in part by the Rett Syndrome Research Foundation (RSRF).



Rett Syndrome (RTT) is a severe neurological disorder diagnosed almost exclusively in girls. Children with RTT appear to develop normally until 6 to 18 months of age, when they enter a period of regression, losing speech and motor skills. Most develop repetitive hand movements, irregular breathing patterns, seizures and extreme motor control problems. RTT leaves its victims profoundly disabled, requiring maximum assistance with every aspect of daily living. There is no cure.

RTT is caused by mutations in a gene (MECP2) that regulates expression of other genes. Genes are made up of long stretches of nucleotide bases that are divided into exons (sequences that code for protein) and introns (non-coding sequences). Genes make proteins in a multi-step process. The first, called transcription, takes place in the cell nucleus where DNA is copied into RNA. The second step involves cutting out the introns and pasting together the exons to make up the mature RNA. This RNA is then translated into proteins.


There is a wealth of data to suggest that MECP2 is a transcriptional repressor, meaning it turns off or down-regulates the production of other proteins by shutting down transcription. To date, a handful of MECP2 target genes have been identified.

The paradigm of one gene to one protein has recently given way to the realization that genes encode multiple proteins through a process called alternative splicing, whereby different combinations of exons are pasted together. Furthermore, genes can also have multiple functions. This phenomenon helps to explain why humans are so much more complex than worms or fruit flies, despite having similar numbers of genes.

Zoghbi and colleagues discovered that the MeCP2 protein is multifunctional. Beyond its role as a transcriptional repressor it also acts as a splicing regulator. In support of this finding Zoghbi and colleagues observed alternative splicing abnormalities in the mutant mouse model for RTT.

"The finding that MeCP2 functions in two steps of RNA processing, regulation of RNA levels and regulation of the variant molecules that can be generated from these RNAs is quite exciting. RNA splicing occurs extensively in the nervous system and is critical for many key neuronal functions. MeCP2’s role in this process might provide insight about RNA molecules whose altered splicing contributes to the diverse features of RTT and related disorders," stated Huda Zoghbi. "Once we discover the RNA changes responsible for various features of RTT, we can begin to explore pharmacologic targets to alleviate the symptoms of the disease."

"There was never a doubt that RTT is a complex disease. However, we now propose that its molecular etiology is also complex: MECP2, the gene mutated in RTT, encodes a protein involved in controlling not only the quantity, but also the quality of the protein repertoire of the cell. Thus, we believe that our findings should modify the framework for the identification of key players in RTT pathogenesis by adding mis-spliced genes to the challenge," said Juan Young, first author of the paper.

Since its inception in late 1999, RSRF has become the largest private source of funds for RTT research in the world. "Mutations in the MECP2 gene can lead not only to RTT but also to autism and a variety of other mental disorders. This newly discovered role of MECP2 might therefore hold broad implications for understanding these devastating disorders and point to much needed treatments," stated Monica Coenraads, co-founder and Director of Research for RSRF.

Monica Coenraads | EurekAlert!
Further information:
http://www.rsrf.org

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>